Production and characterization of murine monoclonal antibody against synthetic peptide of CD34

Human Antibodies

Volumn 22, Issue 1-2, 2013, Pages 1-8

  Maleki, Leili Aghebati ^a,b   Majidi, Jafar ^a,b   Baradaran, Behzad ^a,b   Abdolalizadeh, Jalal ^a,b   Akbari, Aliakbar Movassaghpour ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CD34; Monoclonal antibody; Synthetic peptide

Indexed keywords

AMINOPTERIN; CD34 ANTIBODY; CD34 ANTIGEN; HYPOXANTHINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY; THYMIDINE; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; ASCITES; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WESTERN BLOTTING; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL FUSION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; HUMAN; HYBRIDOMA; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; SYNTHESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD34; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL FUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAINS; MICE; MICE, INBRED BALB C; PEPTIDES;

EID: 84889800443     PISSN: 10932607     EISSN: 1875869X     Source Type: Journal    
DOI: 10.3233/HAB-130265     Document Type: Article

References (22)

1. F. Lanza, L. Healy and D.R. Sutherland, Structural and functional features of the CD34 antigen: an update, Journal of Biological Regulators and Homeostatic Agents 15 (2001), 1-13.
2. D.S. Krause, T. Ito, M.J. Fackler et al., Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells, Blood 84 (1994), 691-701.
3. S.J. Nielsen and K.M.McNagny, Novel functions of the CD34 family, Journal of Cell Science 121 (2008), 3683-3692.
4. D.S. Krause, M.J. Fackler, C.I. Civin and W.S. May, CD34: structure, biology, and clinical utility, Blood 87 (1996), 1-13.
5. W. Qian, L. Wang, B. Li, H. Wang and Sh. Hou, Development of new versions of anti-human CD34 monoclonalantibodies with potentially reduced immunogenicity, Biochemical and Biophysical Research Communications 367 (2008), 497-502.
6. X. Hong, D. Zhang, Y. GuoKöhler and G. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256 (1975), 495-497.
7. H. Modjtahedi, Monoclonal Antibodies as Therapeutic Agents: Advances and Challenges, Iran J Immunol 2(1) (2005), 3-21.
8. D. Schrama, R.A. Reisfeld and J.C. Becker, Antibody targeted drugs as cancer therapeutics, Nature Reviews Drug Discovery 5 (2006), 174-190.
9. A. Orfao, J. Lopez, J. Flores and J. Almeida, Diagnosis of hematological malignancies: new applications for flowcytometry, Hematology 2 (2006), 6-13.
10. W.M. Yokoyama, Production ofMonoclonal Antibodies, Current Protocols in Immunology (1995), 2.5.1-2.5.17.
11. J.E. Liddell and A. Cryer, Myeloma cells, lymphocytes, fusion, in: A Practical Guide to Monoclonal Antibodies, John Wiley and Sons Ltd., England, (1991), p. 67.
12. H. Perlmann and P. Perlmann, Enzyme-linked immunosorbent assay, Cell Biology: A Laboratory Handbook, J. Celis, ed., AcademicPress, Inc., San Diego, CA, 1994, pp. 322-328.
13. R. Hadavi, A.H. Zarnani, N. Ahmadvand, A.R. Mahmoudi, A.A. Bayat and J. Mahmoudian, Production of Monoclonal Antibody against Human Nestin, Avicenna Journal of Medical Biotechnology 2(2) (2010), 69-76.
14. K.S. Sepehr, B. Baradaran, J. Majidi, J. Abdolalizadeh, L. Aghebati and F. Zare Shahneh, Mass-Production and Characterization of Anti-CD20 Monoclonal Antibody in Peritoneum of Balb/c Mice, Advanced Pharmaceutical Bulletin 3(1) (2013), 109-113.
15. L. Aghebati Maleki, J. Majidi, B. Baradaran, J. Abdolalizadeh, T. Kazemi, A. Aghebati Maleki and K. Sineh sepehr, Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice, Advanced Pharmaceutical Bulletin 3(1) (2013), 211-216.
16. D.A. Brooks, I. Beckman, J. Bradley, P.J. McNamara, M.E. Thomas and H. Zola, Human lymphocyte markers defined by antibodies derived fromsomatic cell hybrids. I. A hybridoma secreting antibody against a markerspecific for human B lymphocyte, Clin Exp Immunol 39 (1980), 477-485.
17. Y. Tsurumi, M. Hayakawa, Y. Shibata and Y. Abiko, Production of antibody against a synthetic peptide of Porphyromonas gingivalis 40-kDa outer membrane protein, Journal of Oral Science 45 (2003), 111-116.
18. N. Moniaux, G.C. Varshney et al., Generation and Characterization of Anti-MUC4 Monoclonal Antibodies Reactive with Normal and Cancer Cells in Humans, Journal of Histochemistry and Cytochemistry 52(2) (2004), 253-261.
19. T. Tanaka, D.J. Slamon and M.J. Cline, Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens, Immunology, Proc Nati Acad Sci USA 82 (1985), 3400- 3404.
20. J. Chen, Sh. Rawale et al., Peptide-based Antibodies against Glutathione-binding Domains Suppress Superoxide Production Mediated by Mitochondrial Complex, Journal of Biological Chemistry 285(5) (2010), 3168-3180.
21. K. Hong, S. Kang, K. Lee, G. Ji1 and S. Yoon, Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope, Immune Network 10(6) (2010), 239-246.
22. R.W. Tindle et al., A novel monoclonal antibody BI-3C5 recognisesmyeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow, Leukaemia Research 9(1) (1985), 1-9.